ONCY

#6128
Oncolytics Biotech, Inc. Common Shares
1.13
+7.62%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
1.13
1.13
Годовой диапазон
0.33
1.51
Дневное изменение
+7.62%
Месячное изменение
-1.74%
6-месячное изменение
+6.60%
Годовое изменение
+66.18%
Предыдущее закрытие
1.05
Open
1.13
Bid
Ask
Low
1.13
High
1.13
Объем
13
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 28
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Alberta, Canada
  • FIGI BBG000DVS826
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Новости